Siga Technologies INC Current Income Tax Expense (Benefit)
Siga Technologies INC (SIGA) reported Current Income Tax Expense (Benefit) of $676.70 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-10
- Siga Technologies INC current income tax expense (benefit) for the quarter ending 2018-12-31 was $24.55M, a 8614.14% increase year-over-year.
- Siga Technologies INC current income tax expense (benefit) for the quarter ending 2018-09-30 was -$25.41M, a 18970.85% decline year-over-year.
- Siga Technologies INC current income tax expense (benefit) for the quarter ending 2018-06-30 was $2.85K, a 96.93% decline year-over-year.
- Siga Technologies INC current income tax expense (benefit) for the quarter ending 2018-03-31 was -$2.35K, a 100.00% decline year-over-year.
- Siga Technologies INC current income tax expense (benefit) for fiscal 2025 was $676.70K, a 95.94% decline from fiscal 2024.
- Siga Technologies INC current income tax expense (benefit) for fiscal 2024 was $16.66M, a 32.00% decline from fiscal 2023.
- Siga Technologies INC current income tax expense (benefit) for fiscal 2023 was $24.51M, a 74.35% increase from fiscal 2022.
- Siga Technologies INC current income tax expense (benefit) for fiscal 2022 was $14.06M, a 28.79% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $676.70K 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $16.66M 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $24.51M 10-K · filed 2026-03-10 | |||
| 2022-12-31 | $14.06M 10-K · filed 2025-03-11 | |||
| 2021-12-31 | $19.74M 10-K · filed 2024-03-12 | |||
| 2020-12-31 | $5.56M 10-K · filed 2023-03-02 | |||
| 2019-12-31 | -$519.66K 10-K · filed 2022-03-03 | |||
| 2018-12-31 | $24.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$867.35K derived: sum of 2 quarters · filed 2021-03-04 | -$864.50K derived: sum of 3 quarters · filed 2021-03-04 | -$866.85K 10-K · filed 2021-03-04 |
| 2018-09-30 | -$25.41M 10-Q · filed 2018-11-06 | -$25.41M derived: sum of 2 quarters · filed 2018-11-06 | -$25.41M 10-Q · filed 2018-11-06 | -$25.13M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $2.85K 10-Q · filed 2018-08-07 | $497.00 10-Q · filed 2018-08-07 | $282.17K derived: sum of 3 quarters · filed 2020-03-05 | $416.84K derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | -$2.35K 10-Q · filed 2018-05-04 | $279.32K derived: sum of 2 quarters · filed 2020-03-05 | $413.99K derived: sum of 3 quarters · filed 2020-03-05 | $506.82K derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $281.68K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $416.34K derived: sum of 2 quarters · filed 2020-03-05 | $509.17K derived: sum of 3 quarters · filed 2020-03-05 | $624.24K 10-K · filed 2020-03-05 |
| 2017-09-30 | $134.67K 10-Q · filed 2017-11-07 | $227.49K derived: sum of 2 quarters · filed 2017-11-07 | $342.56K 10-Q · filed 2017-11-07 | $115.00B derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $92.83K 10-Q · filed 2017-08-03 | $207.90K 10-Q · filed 2017-08-03 | $115.00B derived: sum of 3 quarters · filed 2019-03-06 | $115.00B derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $115.00B 10-Q · filed 2017-05-04 | $115.00B derived: sum of 2 quarters · filed 2019-03-06 | $115.00B derived: sum of 3 quarters · filed 2019-03-06 | $115.00B derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $2.16K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $6.16K derived: sum of 2 quarters · filed 2019-03-06 | $6.16K derived: sum of 3 quarters · filed 2019-03-06 | -$6.54K 10-K · filed 2019-03-06 |
| 2016-09-30 | $4.00K 10-Q · filed 2016-11-02 | $4.00K derived: sum of 2 quarters · filed 2016-11-02 | -$8.70K 10-Q · filed 2016-11-02 | $11.00B derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $11.00B derived: sum of 3 quarters · filed 2018-03-06 | $11.00B derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-03-31 | $11.00B 10-Q · filed 2016-05-04 | $11.00B derived: sum of 2 quarters · filed 2018-03-06 | $11.00B derived: sum of 3 quarters · filed 2018-03-06 | $11.00B derived: sum of 4 quarters · filed 2018-03-06 |
| 2015-12-31 | $240.88K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $340.88K derived: sum of 2 quarters · filed 2018-03-06 | $440.88K derived: sum of 3 quarters · filed 2018-03-06 | $440.88K 10-K · filed 2018-03-06 |
| 2015-09-30 | $100.00K 10-Q · filed 2015-10-27 | $200.00K derived: sum of 2 quarters · filed 2015-10-27 | $200.00K 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $100.00K 10-Q · filed 2015-08-04 | $200.00K 10-Q · filed 2015-08-04 | ||
| 2015-03-31 | $100.00K 10-Q · filed 2015-05-06 | |||
| 2014-12-31 | -$40.80K 10-K · filed 2017-03-07 | |||
| 2013-12-31 | $1.98M 10-K · filed 2016-03-04 | |||
| 2012-12-31 | $3.65K 10-K · filed 2015-03-06 | |||
| 2011-12-31 | $20.33K 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |